The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey.

Article Details

Citation
Copy to clipboard

Velcheti V, Viswanathan A, Govindan R

The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey.

J Thorac Oncol. 2006 Jun;1(5):501.

PubMed ID
17409907 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs